FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to pharmaceutics, more specifically to a pharmaceutical product of hyaluronic acid for damages of epithelium and connecting tissue. The pharmaceutical product contains 0.001 % to less than 100 %, at least one physiologically acceptable hyaluronic acid salt having viscosity to equal 0 (zero) mPa·s in the concentration equal to 1 weight/volume in water at 20°C and less 10 mPa·s in the concentration equal to 6 weight/volume % in water at 20°C. What is also presented is using physiologically acceptable hyaluronic acid salt having specified viscosity values for preparing the given pharmaceutical product.
EFFECT: group of inventions provides improved therapeutic efficacy of the pharmaceutical product ensued by using hyaluronic acid salts having very low viscosity and thereby having no effect on the rheological characteristic of the product.
4 cl, 5 ex
Title |
Year |
Author |
Number |
HYDROPHILIC GEL FOR LOCAL DELIVERY OF 5-AMINOLEVULINIC ACID |
2016 |
- Solioz, Andre
- Stowasser, Frank
- Zimmer, Armin
|
RU2723339C2 |
ASSOCIATES OF THE DEPROTONIZED HYALURONIC ACID, A METHOD OF THEIR PREPARING, PHARMACEUTICAL COMPOSITION CONTAINING ASSOCIATES OF THE DEPROTONIZED HYALURONIC ACID AND A METHOD OF ITS PREPARING |
1990 |
- Kal'Man Burger[Hu]
- Geza Takachi Nad'[Hu]
- Ivan Retei[Hu]
- Janosh Illesh[Hu]
- Bela Shtefko[Hu]
- Ehrzhebet Nesmel'I[Hu]
- Ishtvan Gebkhardt[Hu]
- Ishtvan Rats[Hu]
- Arpadne Kiraj[Hu]
- Viktoria Varkon'I[Hu]
|
RU2099350C1 |
PREPARATION FOR HEALING WOUND AND PREVENTION BANDAGE STICKING TO WOUND |
2003 |
- Velebni Vladimir
- Sobotka Lubosh
- Pavek Stanislav
- Ruzhichkova Jana
|
RU2296569C2 |
METHOD OF BIOLOGICALLY ACTIVE COMPOSITION PREPARING |
1991 |
- Burger Kal'Man[Hu]
- Nad' Geza Takachi[Hu]
- Retei Ivan[Hu]
- Illesh Janosh[Hu]
- Shtefko Bela[Hu]
- Nesmel'I Ehrzhebet[Hu]
- Gebkhardt Ishtvan[Hu]
- Rats Ishtvan[Hu]
- Kiraj Arpadne[Hu]
- Varkon'I Viktoria[Hu]
|
RU2021304C1 |
BLADDER INSULATION COMPOSITION CONTAINING CHONDROITIN SULPHATE (20 MG/ML), HYALURONIC ACID (16 MG/ML) AND PHOSPHATE BUFFER (pH 6.1-7.9), WITH INCREASED STORAGE STABILITY FOR CYSTITIS TREATMENT |
2018 |
|
RU2745869C1 |
COMPOSITION FOR INSTILLATION OF URINARY BLADDER WITH INCREASED STABILITY DURING STORAGE, CONTAINING CHONDROITIN SULPHATE (4_5 MG/ML), HYALURONIC ACID (16 MG/ML) AND PHOSPHATE BUFFER (PH 6_1-7_9), FOR TREATING CYSTITIS |
2018 |
|
RU2742277C1 |
REEPITHELIALIZING PHARMACEUTICAL COMPOSITION CONTAINING XANTHANIC PITCH |
2003 |
- Matstsone Marija Gratsija
- Paladino Gratsija
- Marino Klara
- Peri Ornella
- Ehnea Vinchentso
|
RU2297230C2 |
HYDROGEL WATER-SOLUBLE COMPOSITION BASED ON HYALURONIC ACID AND POLYVALENT METAL IONS AND A METHOD FOR PRODUCTION THEREOF |
2019 |
- Ivanov Pavel Leonidovich
- Khabarov Vladimir Nikolaevich
|
RU2710074C1 |
AQUEOUS COMPOSITION FOR INSTILLATION IN BLADDER |
2015 |
- Pradkhan Irina Nikolaevna
- Vorobev Aleksandr Nikolaevich
|
RU2586285C1 |
HEAT-SENSITIVE GEL-FORMING ARTIFICIAL TEAR |
2018 |
- Yamamura, Takeshi
- Yamamuro, Ayaka
- Izukura, Emi
- Kimura, Moto
- Otsuka, Tomohiro
|
RU2710366C1 |